Skip to main content
PolicySpeak
← All files
IPR

Institute of Pharmaceutical Research & Technology (IFET)

Industry association · Greece · EU Transparency Register 605482152677-67

1
position filed
in the 673 files tracked
1
legislative file
of 673 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 172 other organisations on this site, they rank #153 by legislative files engaged, a count of participation, not a measure of influence.

0.3
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since

Declares membership of

  • Πανελλήνια Ένωση Φαρμακοβιομηχανίας (ΠΕΦ)
  • https://www.pef.gr/

Self-declared to the EU Transparency Register (snapshot 20 Oct 2026).

Register category
Other organisations
Registered as
Ινστιτούτο Φαρμακευτικής Έρευνας & Τεχνολογίας ΜΑΕ (IFET)
Head office
Παλλήνη, Greece

Self-declared to the EU Transparency Register (snapshot 20 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Institute in PolicySpeak: request access →

Follow Institute of Pharmaceutical Research & Technology (IFET)

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Institute of Pharmaceutical Research & Technology (IFET)? so we know who speaks for it.

Their record over time

Institute of Pharmaceutical Research & Technology (IFET) filed 1 position on 27 Feb 2025, across 1 of the 673 legislative files tracked here.

What they argued

Critical Medicines Actfiled 27 Feb 2025source

Please find attached the contribution of Institute of Pharmaceutical Research & Technology (IFET SA) - Supply chain challenges. EU-Level Coordination: Enhancing coordination at the EU level to effectively tackle supply chain challenges. This includes harmonizing regulations and fostering collaboration among Member States to ensure a unified approach to critical medicine supply.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Institute of Pharmaceutical Research & Technology (IFET) next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Institute of Pharmaceutical Research & Technology (IFET)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.